Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

International Journal of Molecular Sciences, 2024

Machine Learning Identifies Key Proteins in Primary Sclerosing Cholangitis Progression and Links High CCL24 to Cirrhosis

Snir T, Greenman R, Aricha R et al.

New England Journal of Medicine, 2024

The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1

Oikonomou V., Smith G., Constantine G. et al.

European Heart Journal: Acute Cardiovascular Care, 2024

Targeted proteomic profiling of cardiogenic shock in the cardiac intensive care unit

Patel S., Lopes M., Morrow D. et al.

Analytical Chemistry, 2024

Sample-Treatment with the Virucidal β-Propiolactone Does Not Preclude Analysis by Large Panel Affinity Proteomics, Including the Discovery of Biomarker Candidates

Beutgen V., Bhagwat A., Steitz A. et al.

GeroScience, 2024

Mediating and moderating effects of plasma proteomic biomarkers on the association between poor oral health problems and incident dementia: The UK Biobank study

Beydoun H., Beydoun M., Noren Hooten N. et al.

JAMA Cardiology, 2024

High Throughput Plasma Proteomics and Risk of Heart Failure and Frailty in Late Life

Ramonfaur D., Buckley L., Arthur V. et al.

International Journal of Molecular Sciences, 2024

ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19

Sun J., Edsfeldt A., Svensson J. et al.

Journal of Clinical Medicine, 2024

A Search for New Biological Pathways in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy by Proteomic Research

Menéndez-Valladares P., Acevedo Aguilera R., Núñez-Jurado D. et al.

Nature Aging, 2024

A plasma protein-based risk score to predict hip fractures

Austin T., Nethander M., Fink H. et al.

Movement Disorders, 2024

Increased CSF DOPA Decarboxylase Correlates with Lower DaT‐SPECT Binding: Analyses in Biopark and PPMI Cohorts

Khosousi S., Sturchio A., Appleton E. et al.

Archives of Dermatological Research, 2024

Genetic analyses unravel the causal association of cytokine levels on lichen simplex chronicus risk: insights from a mendelian randomization study

Yu H., Ou G.

Thrombosis and Haemostasis, 2024

Exploring Causal Relationships between Circulating Inflammatory Proteins and Thromboangiitis Obliterans: A Mendelian Randomization Study

Zhang B., He R., Yao Z. et al.

PROTEOMICS, 2024

Capillary blood self‐collection for high‐throughput proteomics

El‐Sabawi B., Huang S., Tanriverdi K. et al.

Science Translational Medicine, 2024

Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes

Chen Z., Satake E., Pezzolesi M. et al.

International Journal of Obesity, 2024

Metabolic profiling of galectin-1 and galectin-3: a cross-sectional, multi-omics, association study

Fryk E., Rodrigues Silva V., Strindberg L. et al.

International Urology and Nephrology, 2024

Inflammatory cytokines and their potential role in kidney stone disease: a Mendelian randomization study

Yuan D., Yang J., Wu W. et al.

Biomedicines, 2024

Activation of CD14+ Monocytes via the IFN-γ Signaling Pathway Is Associated with Immune-Related Adverse Events in Hepatocellular Carcinoma Patients Receiving PD-1 Inhibition Combination Therapy

Song Y., Pan S., Tian J. et al.

BMC Medical Genomics, 2024

Causal roles and clinical utility of cardiovascular proteins in colorectal cancer risk: a multi-modal study integrating mendelian randomization, expression profiling, and survival analysis

Tan C., Li Y., Wang K. et al.

iScience, 2024

Chemotherapy-induced intestinal epithelial damage directly promotes galectin-9-driven modulation of T cell behavior

Jansen S., Cutilli A., de Koning C. et al.

Scientific Reports, 2024

The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population

Grauen Larsen H., Sun J., Sjögren M. et al.

4555 publications